Si prevede che la dimensione del mercato del trattamento delle infezioni del tratto urinario raggiungerà i 13,02 miliardi di dollari entro il 2031, rispetto ai 10,10 miliardi di dollari del 2023. Si prevede che il mercato registrerà un CAGR del 3,2% nel 2022-2031. Lo sviluppo di nuovi trattamenti alternativi, come gli integratori alimentari per le infezioni del tratto urinario, rimarrà probabilmente una delle principali tendenze del mercato del trattamento delle infezioni del tratto urinario.CAGR of 3.2% in 2022–2031. Development of novel alternative treatments such as nutritional supplements for UTI are likely to remain key urinary tract infection treatment market trends.
Analisi di mercato del trattamento delle infezioni del tratto urinario
Le infezioni del tratto urinario (UTI) si verificano quando i batteri, per lo più dalla pelle o dal retto, entrano nell'uretra e infettano il tratto urinario. Sebbene possano essere colpite diverse parti del tratto urinario, il tipo più diffuso di UTI è un'infezione della vescica ( cistite). L'infezione renale (pielonefrite), d'altro canto, è meno comune ma più grave delle infezioni della vescica. La crescente prevalenza di UTI aumenta la domanda di terapie di prevenzione e trattamento come gli antibiotici.UTIs) occur when bacteria, mostly from the skin or rectum, enter the urethra and infect the urinary tract. Although several parts of the urinary tract can be affected, the most prevalent type of UTI is a bladder UTIs increase the demand for its prevention and treatment therapies such as antibiotics.
Panoramica del mercato del trattamento delle infezioni del tratto urinario
Si prevede che i progressi nelle tecnologie di diagnostica molecolare, come il monitoraggio remoto dei pazienti e l'intelligenza artificiale, miglioreranno l'efficienza delle procedure diagnostiche. La maggior parte degli operatori del settore si concentra sullo sviluppo e sul lancio di kit e apparecchiature avanzati con l'obiettivo di improvvisare il processo di diagnostica domiciliare. Ad esempio, a febbraio 2024, PathogenDx ha lanciato il suo test D3 Array-UTI. Questo test è un test PCR multiplex in grado di rilevare 26 diversi patogeni e 12 marcatori genetici di resistenza agli antibiotici. I risultati del test possono aiutare i medici a fornire un trattamento rapido per le infezioni delle vie urinarie. Inoltre, si prevede che la crescente popolazione geriatrica porterà a un aumento della domanda di trattamenti per le infezioni delle vie urinarie nel prossimo decennio.PathogenDx, launched its D3 Array-UTI test. This test is a multiplexed PCR test that is capable of detecting 26 different pathogens and 12 antibiotic resistance gene markers. The test results can help clinicians deliver rapid treatment for UTI. Additionally, the rising geriatric population is expected to bring an uptake in the demand for UTI treatments in the coming decade.
Personalizza questo report in base alle tue esigenze
Riceverai la personalizzazione gratuita di qualsiasi report, comprese parti di questo report, o analisi a livello nazionale, pacchetto dati Excel, oltre a usufruire di grandi offerte e sconti per start-up e università
Mercato del trattamento delle infezioni del tratto urinario: approfondimenti strategici
- Scopri le principali tendenze di mercato in questo rapporto.Questo campione GRATUITO includerà analisi di dati che spaziano dalle tendenze di mercato alle stime e alle previsioni.
Driver e opportunità di mercato per il trattamento delle infezioni del tratto urinario
Casi crescenti di infezioni del tratto urinario favoriscono il mercato
Increasing prevalence of UTI is one of the prominent factors driving the growth of the urinary tract infection treatment market. For instance, according to a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, UTIs accounts for an estimated 6 million physicians visits each year in the US. Propelling incidences of UTIs is a major driver of global urinary tract infection treatment market share.
Increasing R&D Activities– An Opportunity in UTI Treatment
R&D in UTI treatment is expected to offer lucrative growth opportunities for players in the global urinary tract infection treatment market. Further, in February 2020, a new antibiotic treatment for urinary and bacterial infections, developed by Venatorx Pharmaceuticals and Global Antibiotic Research & Development Partnership (GARDP) is under final review by the FDA. The treatment represents a significant advancement in treating complicated urinary tract infections and serious infections caused by highly resistant bacteria.
Urinary Tract Infection Treatment Market Report Segmentation Analysis
Key segments that contributed to the derivation of the urinary tract infection treatment market analysis are drug class, indication, and distribution channel.
- Based on drug class the market is segmented into penicillin and combinations, quinolones, cephalosporin, aminoglycoside antibiotics, sulphonamides, and nutritional supplements. The quinolones segment held the largest market share in 2023.
- By Indication the market is bifurcated into complicated urinary tract infection and uncomplicated urinary tract infection. The complicated urinary tract infection segment held the largest share of the market in 2023.
- In terms of distribution channel, the market is segmented into hospital pharmacies, gynaecology and urology clinics, retail pharmacies and drug stores, online drug stores. The hospital pharmacies segment dominated the market in 2023.
Urinary Tract Infection Treatment Market Share Analysis by Geography
The geographic scope of the urinary tract infection treatment Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the urinary tract infection treatment Market. The US is estimated to hold the largest share of the North America urinary tract infection treatment market. The growth in the US is estimated due to rising incidence of UTI, the rising development in the field of home diagnostics for UTI, and the presence of the startups offering treatments for UTI. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
Urinary Tract Infection Treatment Market Regional Insights
The regional trends and factors influencing the Urinary Tract Infection Treatment Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Urinary Tract Infection Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Urinary Tract Infection Treatment Market
Urinary Tract Infection Treatment Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 10.10 Billion |
| Market Size by 2031 | US$ 13.02 Billion |
| Global CAGR (2023 - 2031) | 3.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered | By Drug Class
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
Urinary Tract Infection Treatment Market Players Density: Understanding Its Impact on Business Dynamics
The Urinary Tract Infection Treatment Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Urinary Tract Infection Treatment Market are:
- Almirall SA
- Dr. Reddys Laboratories Ltd
- Allergan
- GlaxoSmithKline PLC
- Shionogi & Co. Ltd
- Novartis AG
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Urinary Tract Infection Treatment Market top key players overview
Urinary Tract Infection Treatment Market News and Recent Developments
Il mercato del trattamento delle infezioni del tratto urinario viene valutato raccogliendo dati qualitativi e quantitativi dopo la ricerca primaria e secondaria, che include importanti pubblicazioni aziendali, dati di associazioni e database. Di seguito è riportato un elenco degli sviluppi nel mercato del trattamento e delle strategie per le infezioni del tratto urinario:
- Allecra Therapeutics ha annunciato l'approvazione della FDA statunitense per EXBLIFEP per il trattamento delle infezioni complicate del tratto urinario, tra cui la pielonefrite, nei pazienti di età pari o superiore a 18 anni. L'azienda ha inoltre ricevuto un'estensione di esclusività di commercializzazione di cinque anni dalla FDA come parte del Generating Antibiotic Incentives Now Act (GAIN Act). Il GAIN Act, promulgato dal Congresso degli Stati Uniti, incentiva la creazione di nuove terapie anti-infettive offrendo vantaggi ai produttori di prodotti per malattie infettive qualificate (QIDP). (Fonte: Allecra Therapeutics GmbH, Newsletter, 2024).
- NRx Pharmaceuticals ha annunciato che la FDA accetta la domanda di Investigational New Drug (IND) per il suo NRX-101 per le infezioni delle vie urinarie complicate. L'autorizzazione IND avvierà uno studio di registrazione di fase 2 per indagare la sicurezza e l'efficacia di NRX-101 nei pazienti con infezioni delle vie urinarie complicate. (Fonte: NRx Pharmaceuticals, sito Web aziendale, 2023).
Copertura e risultati del rapporto di mercato sul trattamento delle infezioni del tratto urinario
Il rapporto "Dimensioni e previsioni del mercato del trattamento delle infezioni del tratto urinario (2021-2031)" fornisce un'analisi dettagliata del mercato che copre le seguenti aree:
- Dimensioni e previsioni del mercato a livello globale, regionale e nazionale per tutti i segmenti di mercato chiave coperti dall'ambito
- Dinamiche di mercato come fattori trainanti, vincoli e opportunità chiave
- Principali tendenze future
- Analisi dettagliata delle cinque forze PEST/Porter e SWOT
- Analisi di mercato globale e regionale che copre le principali tendenze di mercato, i principali attori, le normative e gli sviluppi recenti del mercato
- Analisi del panorama industriale e della concorrenza che copre la concentrazione del mercato, l'analisi della mappa di calore, i principali attori e gli sviluppi recenti
- Profili aziendali dettagliati
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For